(23S,24S)-3-beta-23,24-trihydroxy spirosta-5,25(27)-dien-1-beta-yl-O-(2,3-di-O-acetyl-alpha-L-rhamnopyranosyl)-(1→2)-O-[beta-D-xylopyranosyl-(1→3)]-alpha-L-arabinopyranoside - Compound Card

(23S,24S)-3-beta-23,24-trihydroxy spirosta-5,25(27)-dien-1-beta-yl-O-(2,3-di-O-acetyl-alpha-L-rhamnopyranosyl)-(1→2)-O-[beta-D-xylopyranosyl-(1→3)]-alpha-L-arabinopyranoside

Select a section from the left sidebar

(23S,24S)-3-beta-23,24-trihydroxy spirosta-5,25(27)-dien-1-beta-yl-O-(2,3-di-O-acetyl-alpha-L-rhamnopyranosyl)-(1→2)-O-[beta-D-xylopyranosyl-(1→3)]-alpha-L-arabinopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Saponin
Canonical Smiles CC(=O)OC1[C@H](O[C@@H]2[C@@H](OC[C@@H](C2O[C@@H]2OC[C@H](C([C@@H]2O)O)O)O)O[C@@H]2C[C@H](O)CC3=CC[C@@H]4[C@@H]([C@@]23C)CC[C@]2([C@H]4C[C@H]3[C@@H]2[C@H](C)[C@@]2(O3)OCC(=C)C(C2O)O)C)OC([C@@H]([C@@H]1OC(=O)C)O)C
InChI InChI=1S/C47H70O20/c1-18-15-60-47(41(57)33(18)53)19(2)32-30(67-47)14-27-25-9-8-23-12-24(50)13-31(46(23,7)26(25)10-11-45(27,32)6)64-43-39(37(29(52)17-59-43)65-42-36(56)35(55)28(51)16-58-42)66-44-40(63-22(5)49)38(62-21(4)48)34(54)20(3)61-44/h8,19-20,24-44,50-57H,1,9-17H2,2-7H3/t19-,20?,24+,25+,26-,27-,28+,29-,30-,31+,32-,33?,34-,35?,36-,37?,38-,39-,40?,41?,42-,43-,44-,45-,46-,47-/m0/s1
InChIKey QZJCQJZANABERY-QRHUQJHNSA-N
Formula C47H70O20
HBA 20
HBD 8
MW 955.06
Rotatable Bonds 8
TPSA 288.28
LogP -0.53
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 67
Formal Charge 0
Fraction CSP3 0.87
Exact Mass 954.45
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria trifasciata Dracaenaceae Plantae 39534

Showing of synonyms

  • Teponno RB, Tanaka C, et al. (2016). Trifasciatosides A-J, Steroidal Saponins from Sansevieria trifasciata.. Chemical & pharmaceutical bulletin,2016, 64(9), 1347-1355. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7OCCC(OC8CCCCO8)C7OC9CCCCO9

Level: 3

Mol. Weight: 955.06 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCCC7)C7OC8CCCCO8

Level: 2

Mol. Weight: 955.06 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCC7)CC7OC8CCCCO8

Level: 2

Mol. Weight: 955.06 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 955.06 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCCCO7

Level: 1

Mol. Weight: 955.06 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 955.06 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 955.06 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6

Level: 0

Mol. Weight: 955.06 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 955.06 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.1
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
9186.76
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
1201369.32

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.58
Plasma Protein Binding
79.14
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
2.59
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Toxic
Bioconcentration Factor
-27939.29
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.79
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-2180429729.92
Rat (Acute)
4.45
Rat (Chronic Oral)
7.28
Fathead Minnow
2752334.06
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
245233941.41
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-120.04
Log(P)
0.78
Log S
-3.23
Log(Vapor Pressure)
-8075272.9
Melting Point
263.17
pKa Acid
-58757.07
pKa Basic
-457.03
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.7207

Download SDF